πŸ›’ 0
Antioxidant & Cellular Defense

Glutathione

Master Antioxidant Tripeptide (Molecular Mass: 307.32 g/mol)

ZAR 1,050.00
Unit Cost: ZAR 3.50 / mg
❄️ In Stock β€” Ready for Cold-Chain Dispatch
Loading shipping schedule...
Select Requisition Profile:
Allocation Quantity:
βœ“ >99.2% HPLC Purity
🧊 Cold-Chain Courier
πŸ”’ Secure EFT Payment
πŸ‡ΏπŸ‡¦ Synthesised in JHB

Batch Integrity Certificate

Analysis performed by Johannesburg Chemical Synthesis Lab Environment

HPLC: 99.68%

Batch ID

#GLU-LOADING

CAS Number

70-18-8

Appearance

Lyophilized White Powder

Validation Date

Loading date...

Clinical Dossier: Glutathione

Comprehensive pharmacological data, standardized research protocols, and clinical cellular detoxification parameters for our stable tripeptide formulation.

🧬 Pharmacological Profile

Glutathione is universally recognized as the master intracellular antioxidant. A biologically active tripeptide, it is composed of three amino acids: L-glutamine, L-cysteine, and L-glycine. In its reduced form (GSH), it serves as a critical electron donor, neutralizing reactive oxygen species (ROS) and free radicals before they can trigger cascading lipid peroxidation, DNA mutations, and mitochondrial membrane damage.

The primary therapeutic mechanism relies on Phase II conjugation pathways within hepatic tissue. By binding directly to electrophilic xenobiotics, heavy metals, and reactive metabolites via Glutathione S-Transferase (GST) enzymes, GSH renders toxic compounds water-soluble, facilitating prompt cellular export and renal clearance.

Additionally, Glutathione actively maintains other antioxidants in their active, reduced states. It recycles oxidized Vitamin C (ascorbic acid) and Vitamin E back into their functional configurations, preserving a robust systemic redox barrier against heavy environmental and metabolic oxidative loads.

πŸ“Š Observed Clinical Efficacy

Because oral Glutathione is rapidly degraded by peptidases in the gastrointestinal tract, systemic and cellular research models rely strictly on parenteral or lyophilized configurations to bypass mucosal degradation and achieve absolute bioavailability.

Under clinical observation, direct systemic delivery of reduced Glutathione has shown remarkable protective efficacy against oxidative liver damage, rapidly normalizing elevated transaminase enzyme profiles (ALT and AST). It also mitigates severe cellular neuro-inflammation (commonly presented as cognitive "brain fog") by restoring healthy mitochondrial respiration across the blood-brain barrier.

Furthermore, standard dermal modeling reveals significant anti-melanogenic capabilities. By binding to and inhibiting the active site of the copper-containing tyrosinase enzyme, GSH forcefully shifts the synthesis of melanin from dark eumelanin to lighter pheomelanin, producing a profound skin-lightening effect and reducing hyperpigmented lesions under research conditions.

⏱️ Standardized Research Protocol

The standard research framework follows a consistent daily or bi-weekly scheduling format to preserve baseline plasma availability margins during structural restoration phases.

Phase Duration Weekly Reference Scale
Initiation / Mild Weeks 1 - 2 2x Weekly (100mg per admin)
Standard Detox Weeks 3 - 6 2x Weekly (200mg per admin)
Intense Cellular Defense Weeks 7 - 8 3x Weekly (200mg per admin)
Maintenance Cycle End 1x Weekly (100mg per admin)

πŸ§ͺ Reconstitution & Handling

Glutathione is dispatched from our Johannesburg laboratory environment as an exact, lyophilized cake block. It must be carefully reconstituted using sterile Bacteriostatic Water (BAC) prior to laboratory evaluation loops.

  • Inject BAC liquid slowly against the internal side of the glass container to avoid structural stress.
  • Do not shake the container. Swirl with a gentle rolling hand motion until the clear solute configuration has completely dissolved. Store at 2Β°C to 8Β°C immediately.

πŸ“ Reconstitution Math (300mg):

Adding 3mL of Bacteriostatic Water to a 300mg vial yields a concentration of 100mg per 1mL.

(e.g., A standard 100mg reference dose equates to 100 units / 1.0mL on a standard syringe).

⚠️ Research Requisition Disclaimer (SAHPRA Compliance)

All synthetic peptides and clinical compounds supplied by Slim Science are synthesized strictly for laboratory evaluation, biochemical profiling, and in-vitro research parameters. These formulations have not been evaluated by the South African Health Products Regulatory Authority (SAHPRA) and are not registered under the Medicines and Related Substances Act, 101 of 1965. They are not intended for human diagnostic, therapeutic, or clinical intervention.